NUTX NUTEX HEALTH INC revenue, earnings and financials
For the quarter ended June 30, 2026, NUTEX HEALTH INC reported revenue of $211M (down 13.6% from a year earlier), net income of $65.8M and diluted EPS of $9.38; over the last four quarters revenue was $847M and net income $180M; for the fiscal year ended December 2025 revenue was $875M, up 82.4% on the year before.
NUTX annual revenue and earnings
- Fiscal year ended Dec 2025: revenue $875M, gross profit $444M, operating income $276M, net income $70.8M (margin 8.1%), EPS $10.48
- Fiscal year ended Dec 2024: revenue $480M, gross profit $196M, operating income $131M, net income $52.1M (margin 10.9%), EPS $9.69
- Fiscal year ended Dec 2023: revenue $248M, gross profit $34.8M, operating income −$31.8M, net income −$45.8M (margin -18.5%), EPS −$10.39
- Fiscal year ended Dec 2022: revenue $219M, gross profit $15.4M, operating income −$407M, net income −$425M (margin -193.7%), EPS −$100.36
- Fiscal year ended Dec 2021: revenue $332M, gross profit $179M, operating income $170M, net income $133M (margin 40.0%), EPS $0.22
NUTX quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue $211M (down 13.6% year over year), net income $65.8M, EPS $9.38
- Quarter ended Mar 31, 2026: revenue $216M (up 2.2% year over year), net income $46.8M, EPS $6.52
- Quarter ended Dec 31, 2025 (from the annual report): revenue $152M (down 41.1% year over year), net income $11.8M, EPS $2.34
- Quarter ended Sep 30, 2025: revenue $268M (up 239.9% year over year), net income $55.4M, EPS $7.76
- Quarter ended Jun 30, 2025: revenue $244M (up 220.7% year over year), net income −$17.7M, EPS −$2.95
- Quarter ended Mar 31, 2025: revenue $212M (up 214.0% year over year), net income $21.2M, EPS $3.33
- Quarter ended Dec 31, 2024: revenue $258M (up 269.8% year over year), net income $61.7M, EPS $11.12
- Quarter ended Sep 30, 2024: revenue $78.8M (up 25.6% year over year), net income −$8.79M, EPS −$1.72
- Quarter ended Jun 30, 2024: revenue $76.1M (up 29.1% year over year), net income −$364K, EPS −$0.07
- Quarter ended Mar 31, 2024: revenue $67.5M (up 19.7% year over year), net income −$364K, EPS −$0.08
- Quarter ended Dec 31, 2023: revenue $69.7M (up 29.7% year over year), net income −$31.6M, EPS −$7.47
- Quarter ended Sep 30, 2023: revenue $62.7M (up 120.9% year over year), net income −$5.54M, EPS −$1.25
- Quarter ended Jun 30, 2023: revenue $58.9M (up 1.5% year over year), net income −$3.48M, EPS −$0.79
- Quarter ended Mar 31, 2023: revenue $56.3M (down 28.8% year over year), net income −$5.15M, EPS −$0.12
- Quarter ended Dec 31, 2022: revenue $53.7M (down 63.9% year over year), net income −$14.8M, EPS −$0.02
- Quarter ended Sep 30, 2022: revenue $28.4M (down 75.9% year over year), net income −$412M, EPS −$0.62
- Quarter ended Jun 30, 2022: revenue $58.0M (down 7.6% year over year), net income −$19.3M, EPS −$0.03
- Quarter ended Mar 31, 2022: revenue $79.1M (up 3828.2% year over year), net income $21.4M, EPS $0.04
- Quarter ended Dec 31, 2021 (from the annual report): revenue $149M, net income $32.9M, EPS $0.32
- Quarter ended Sep 30, 2021: revenue $118M, net income $74.5M, EPS $0.09
NUTX cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow $248M, share buybacks $5.00M
- Fiscal year ended Dec 2024: operating cash flow $23.2M, share buybacks $0
- Fiscal year ended Dec 2023: operating cash flow $1.26M, share buybacks $0
- Fiscal year ended Dec 2022: operating cash flow $50.6M, share buybacks n/a
- Fiscal year ended Dec 2021: operating cash flow $173M, share buybacks n/a
NUTX balance sheet
- Jun 30, 2026: cash $205M, total assets $965M, total liabilities $457M, shareholders' equity $394M, long-term debt $31.1M
- Mar 31, 2026: cash $207M, total assets $957M, total liabilities $515M, shareholders' equity $346M, long-term debt $24.3M
- Dec 31, 2025: cash $186M, total assets $919M, total liabilities $495M, shareholders' equity $329M, long-term debt $29.2M
- Sep 30, 2025: cash $166M, total assets $965M, total liabilities $526M, shareholders' equity $317M, long-term debt $25.6M
- Jun 30, 2025: cash $96.7M, total assets $841M, total liabilities $504M, shareholders' equity $235M, long-term debt $20.5M
- Mar 31, 2025: cash $84.7M, total assets $762M, total liabilities $507M, shareholders' equity $177M, long-term debt $21.7M
- Dec 31, 2024: cash $40.6M, total assets $655M, total liabilities $467M, shareholders' equity $132M, long-term debt $22.5M
- Sep 30, 2024: cash $46.9M, total assets $438M, total liabilities $359M, shareholders' equity $60.4M, long-term debt $26.8M
What is NUTX's revenue?
NUTEX HEALTH INC reported $847M of revenue over its last four quarters, through June 30, 2026.
Is NUTX profitable?
Yes. NUTEX HEALTH INC earned $180M over the last four quarters.
What is NUTX's EPS?
Diluted earnings per share over the last four quarters were $26.00; $9.38 in the latest quarter.